Position in VKTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$711,194
New position
Shares Held
21,856
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.80325768667643.ToString("F0")%
Shared 0.ToString("F0")%
None 0.19674231332357248.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NewEdge Wealth, LLC holds $20,244,273 across 19 Biotechnology names. VKTX ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,788 | $4,370,733 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,201 | $3,044,334 | |
| 3 | BHVN |
Biohaven Ltd.
|
246,503 | $2,085,415 | |
| 4 | EXEL |
Exelixis, Inc.
|
42,331 | $1,815,576 | |
| 5 | INVA |
Innoviva, Inc.
|
77,134 | $1,797,222 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
27,887 | $1,124,124 | |
| 7 | NVAX |
Novavax Inc
|
130,000 | $1,058,200 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
This page
|
21,856 | $711,194 |
All Filings in VKTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $711,194 | 21,856 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||